Karisch R, Fernandez M, Taylor P, Virtanen C, St-Germain JR, Jin LL, Harris IS, Mori J, Mak TW, Senis YA, Östman A, Moran MF, Neel BG Global proteomic assessment of the classical protein-tyrosine phosphatome and “redoxome”. Cell 2011, 146(5):826-40
Brazón J, Hughes CE, Mori J, Sevcik C, D'suze G, Watson SP Tityus discrepans scorpion venom activates platelets through GPVI and a novel Src-dependent signaling pathway. Platelets 2011, 22(3):165-72
Ellison S, Mori J, Barr AJ, Senis YA CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases. J Thromb Haemost 2010, 8(7):1575-83
Hughes CE, Pollitt AY, Mori J, Eble JA, Tomlinson MG, Hartwig JH, O’Callaghan CA, Fütterer K, Watson SP CLEC-2 activates Syk through Dimerisation. Blood 2010, 115(14):2947-55
Spalton, JC, Mori J, Pollitt, AY, Hughes CE, Eble JA and Watson SP The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signalling in platelets. J Thromb Haemost 2009, 7(7):1192-9
Mori J, Pearce AC, Spalton JC, Grygielska B, Eble JA, Tomlinson MG, Senis YA, Watson SP G6b-B Inhibits Constitutive and Agonist-induced Signaling by Glycoprotein VI and CLEC-2. J Biol Chem 2008, 283(51):35419-27
Takahashi-Yanaga F, Mori J, Matsuzaki E, Watanabe Y, Hirata M, Miwa Y, Morimoto S, Sasaguri T Involvement of GSK-3b and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells. J Biol Chem 2006, 281(50):38489-97
Mori J, Takahashi-Yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma. Experimental Cell Research 2005, 310(2):426-33